For VLA to "aggressively expand" its Phase 1 trials into...

For VLA to "aggressively expand" its Phase 1 trials into different cancer types indicates to me that the doctors & people doing the trials, along with the MD & probably some of the largest investors are confident that the product not only works, but has a high chance of success.

It seems that the management think the Big Pharma want more data & comprehensive proof that the CVA 21 works across the board to cough up a large sum for buyout... when proven VLA would certainly be more valuable, however, it could be argued that the "goal" could be achieved without spreading the bases more & just concentrating on what we are doing now. We need to focus on the game plan which is a buyout by a big pharma. I think this can be achieved by just employing the right person.